CYTLIMIC
CYTLIMIC is a biotechnology company developing immunotherapy products for the treatment of cancer, including a cancer peptide vaccine. CYTLIMIC’s products aim to activate immune systems to attack cancer cells while enabling patients to maintain a high quality-of-life during treatment.
CYTLIMIC
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2016-12-16
Address:
Higashi-shinagawa, Tokyo, Japan
Country:
Japan
Website Url:
http://www.cytlimic.com
Total Employee:
1+
Status:
Active
Total Funding:
20.85 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Nginx
Current Advisors List
Current Employees Featured
Founder
Investors List
SMBC Venture Capital
SMBC Venture Capital investment in Series B - Cytlimic
Fast Track Initiative, Inc.
Fast Track Initiative, Inc. investment in Series B - Cytlimic
NEC Capital Solutions
NEC Capital Solutions investment in Series B - Cytlimic
Fast Track Initiative, Inc.
Fast Track Initiative, Inc. investment in Seed Round - Cytlimic
Fast Track Initiative, Inc.
Fast Track Initiative, Inc. investment in Series A - Cytlimic
NEC Capital Solutions
NEC Capital Solutions investment in Series A - Cytlimic
SMBC Venture Capital
SMBC Venture Capital investment in Series A - Cytlimic
Official Site Inspections
http://www.cytlimic.com
- Host name: server-52-85-78-97.ord51.r.cloudfront.net
- IP address: 52.85.78.97
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Cytlimic"
CYTLIMIC - Products, Competitors, Financials, Employees, …
When was CYTLIMIC founded? CYTLIMIC was founded in 2016. Where is CYTLIMIC's headquarters? CYTLIMIC's headquarters is located at MG Meguro Station Building 7F, Tokyo. …See details»
CYTLIMIC Company Profile - Office Locations, Competitors ... - Craft
CYTLIMIC is a biotechnology company developing immunotherapy products for the treatment of cancer. It specializes in clinical trials and nonclinical testing of cancer peptide vaccines as well …See details»
Cytlimic - Funding, Financials, Valuation & Investors - Crunchbase
CYTLIMIC is a biotechnology company that develops immunotherapy products for the treatment of cancer, including a cancer peptide vaccine. ... Experience the new Crunchbase, powered by …See details»
CYTLIMIC Company Profile | Management and Employees List
CYTLIMIC Inc is a company that operates in the Biotechnology industry. It employs 21-50 people and has $1M-$5M of revenue. The company is headquartered in Kamioosaki, Tokyo, Japan. …See details»
Cytlimic Company Profile 2024: Valuation, Funding & Investors
Cytlimic is headquartered in Tokyo, Japan. What industry is Cytlimic in? Cytlimic’s primary industry is Drug Discovery. Is Cytlimic a private or public company? Cytlimic is a Private …See details»
Cytlimic - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Cytlimic . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Employee Profiles 2. Number of Board Member and Advisor Profiles 5. …See details»
CYTLIMIC, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore CYTLIMIC, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news, and 5 literature, Disease Domain:Neoplasms, Technology Platform:Biological products, Drug:CYT …See details»
CYTLIMIC - Overview, News & Competitors | ZoomInfo.com
CYTLIMIC Inc is a company that operates in the Biotechnology industry. It employs 21-50 people and has $1M-$5M of revenue. The company is headquartered in Kamioosaki, Tokyo, Japan. …See details»
CYTLIMIC, Inc.:Company Profile & Technical Research,Competitor …
CYTLIMIC, Inc. is a company that provides Peptide vaccine, Biotechnology, Immunotherapy and more. CYTLIMIC, Inc. is headquartered in Japan Tokyo-to. CYTLIMIC, Inc. was founded in …See details»
Cytlimic - CoBee Company Profile & Funding Rounds
CYTLIMIC is a biotechnology company developing immunotherapy products for the treatment of cancer, including a cancer peptide vaccine. CYTLIMIC’s products aim to activate immune …See details»
NEC aims to discover new drugs harnessing advanced AI technology
Tokyo, December 19, 2016 - NEC Corporation (NEC; TSE: 6701) today announced the establishment of "CYTLIMIC Inc." (CYTLIMIC), a new company that promotes the …See details»
NEC drug development investment, CYTLIMIC, secures 1.3 billion …
Aug 9, 2019 NEC Corporation (NEC; TSE: 6701) and CYTLIMIC Inc. today announced that financing of 1.3 billion yen (around US$ 12 million at current rate) was completed through the …See details»
NEC ventures into the drug discovery business: pursuing the …
On December 19, 2016, as part of efforts to strengthen its healthcare business, NEC announced the establishment of CYTLIMIC Inc., a new company that promotes the development and …See details»
Cytlimic - Crunchbase
CYTLIMIC is a biotechnology company that develops immunotherapy products for the treatment of cancer, including a cancer peptide vaccine. Search Crunchbase Start Free TrialSee details»
Immutep Enters into Clinical Trial Collaboration, Service and …
Jan 7, 2019 CYTLIMIC also has unique intellectual properties of a combination of LAG-3 IgG fusion protein and Poly IC to synergistically boost the effect of peptide vaccine antigens. …See details»
Cytlimic | CipherBio
Explore Cytlimic's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Truth About Cytlimic. Is Cytlimic the Right Choice?
Read reviews of Cytlimic. Write and share your personal story. Your experience will help others make the right buying decision.See details»
This CWO leads systemic approach to combat physician burnout
1 day ago “An organization saying this is very important and we’re going to attend to this and we’re going to start to put some time, energy and money into this is a great first step,” she …See details»
Cytlimic - Updates, News, Events, Signals & Triggers - Crunchbase
CYTLIMIC is a biotechnology company that develops immunotherapy products for the treatment of cancer, including a cancer peptide vaccine. Search Crunchbase Start Free TrialSee details»
Cytlimic - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Jan 13, 2025 CYTLIMIC is a biotechnology company that develops immunotherapy products for the treatment of cancer, including a cancer peptide vaccine. New. Resources. Advanced …See details»